Part ofhealthcare →

HR5160FEDERALpassed_chamber

Passed

Congress proposes reauthorization of stem cell and bone marrow donation programs

Original title: Stem Cell Therapeutic and Research Reauthorization Act of 2025

July 21, 2026

healthcare medical research stem cell research federal funding

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced

Committee

Floor Vote

Passed

Signed

Currently passed_chamber. The next step in the legislative lifecycle is Signed.

Last action

Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.Jul 21, 2026

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

This legislation determines the continued federal funding and operational authority for programs facilitating life-saving transplants for patients with blood cancers and other diseases.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Patients requiring stem cell transplants

The bill reauthorizes programs that manage the registry and inventory of stem cells used for medical treatments.

C.W. Bill Young Cell Transplantation Program

The program's federal authorization is subject to renewal under this legislation.

What changed

Current stage: passed_chamber.

What's next

Signed.

Summary

The Stem Cell Therapeutic and Research Act of 2025 proposes to extend federal support for national stem cell and bone marrow donation programs. The bill is currently awaiting consideration in the Senate.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

This legislation determines the continued federal funding and operational authority for programs facilitating life-saving transplants for patients with blood cancers and other diseases.

Frequently Asked Questions

What does this bill do?

It seeks to reauthorize federal programs related to stem cell and bone marrow research and transplantation.

What is the current status of the bill?

As of September 4, 2025, it has been received in the Senate and placed on the legislative calendar.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift80% confidence

Legislative Reauthorization Cycle

The bill follows a standard reauthorization cycle for federal health programs, indicating a focus on maintaining existing medical infrastructure.

C.W. Bill Young Cell Transplantation Program

Connected Entities

organizationC.W. Bill Young Cell Transplantation Program“A federal program providing support for bone marrow and cord blood transplantati”Map →

organizationSenate Legislative Calendar“The current status location of the bill.”Map →

organizationNational Cord Blood Inventory“A national resource for cord blood units used in medical treatments.”Map →

Analysis Score

0–100

Significance65
How much this matters to a regular citizen
Controversy10
Intensity of disagreement among stakeholders
Entertainment5
Compellingness for a non-policy-wonk reader
Buzz20
Current news / social attention level

Publisher tools